Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants

Archives of Dermatological Research

Volumn 306, Issue 5, 2014, Pages 441-446

  Shen, Zhengyu ^a   Gao, Xing ^b   Ma, Liwei ^b   Zhou, Zengtong ^a   Shen, Xuemin ^a   Liu, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cutaneous; Foxp3; Immunohistochemistry; Interleukin 17; Lichen planus; Oral

Indexed keywords

INTERLEUKIN 17; PARAFFIN; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; IMMUNOPATHOLOGY; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN DISEASE; YOUNG ADULT; BIOSYNTHESIS; CASE CONTROL STUDY; EPITHELIUM CELL; IMMUNOLOGY; KERATINOCYTE; METABOLISM; MOUTH MUCOSA; PATHOLOGY; PILOT STUDY; SKIN; TH17 CELL;

ADULT; AGED; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; KERATINOCYTES; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; PILOT PROJECTS; SKIN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; YOUNG ADULT;

EID: 84903752177     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1429-3     Document Type: Article

References (27)

1. Abdel-Latif AM, Abuel-Ela HA, El-Shourbagy SH (2009) Increased caspase-3 and altered expression of apoptosis- associated proteins, Bcl-2 and Bax in lichen planus. Clin Exp Dermatol 34:390-395
2. Baccaglini L, Thongprasom K, Carrozzo M, Bigby M (2013) Urban legends series: lichen planus. Oral Dis 19:128-143
3. Boyd AS, Neldner KH (1991) Lichen planus. J Am Acad Dermatol 25:593-619
4. Farhi D, Dupin N (2010) Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 28:100-108
5. Hasséus B, Jontell M, Bergenholtz G, Dahlgren UI (2004) Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin. Clin Exp Immunol 136:483-489 (Pubitemid 38703682)
6. Hu Y, Shen F, Crellin NK, Ouyang W (2011) The IL-17 pathway as a major therapeutic target in autoimmune diseases. Ann N Y Acad Sci 1217:60-76
7. Irvine C, Irvine F, Champion RH (1991) Long-term follow-up of lichen planus. Acta Derm Venereol 71:242-244
8. Lage D, Pimentel VN, Soares TC, Souza EM, Metze K, Cintra ML (2011) Perforin and granzyme B expression in oral and cutaneous lichen planus: a comparative study. J Cutan Pathol 38:973-978
9. Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z, Zheng SG (2012) Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 4:22-28
10. Mai J, Wang H, Yang XF (2010) Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci 15:986-1006
11. Miyara M, Sakaguchi S (2011) Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 89:346-351
12. Miossec P, Kolls JK (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11:763-776
13. Pereira JS, Monteiro BV, Nonaka CF, Silveiraé J, Miguel MC (2012) FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions. Int J Exp Pathol 93:287-294
14. Piccinni MP, Lombardelli L, Logiodice F et al (2013) Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Dis. doi:10.1111/odi.12094
15. Ragaz A, Ackerman AB (1981) Evolution, maturation, and regression of lesions of lichen planus: new observations and correlations of clinical and histologic findings. Am J Dermatopathol 3:5-25 (Pubitemid 11114743)
16. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus: a review. J Oral Pathol Med 39:729-734
17. Santoro A, Majorana A, Bardellini E et al (2004) Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus. Am J Clin Pathol 121:758-764 (Pubitemid 38534009)
18. Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F (2003) NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 201:466-472 (Pubitemid 37408268)
19. Scully C, Carrozzo M (2008) Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 46:15-21 (Pubitemid 350266149)
20. Shaker O, Hassan AS (2012) Possible role of interleukin-17 in the pathogenesis of lichen planus. Br J Dermatol 166:1367-1368
21. Tao XA, Li CY, Xia J et al (2009) Differential gene expression profiles of whole lesions from patients with oral lichen planus. J Oral Pathol Med 38:427-433
22. Tao XA, Xia J, Chen XB et al (2010) FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis 16:76-82
23. van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32:507-512
24. Vered M, Fürth E, Shalev Y, Dayan D (2013) Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters. Clin Oral Investig 17:1365-1373
25. Wang H, Luo Z, Lei L et al (2013) Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum. Inflammation 36:696-704
26. Xie S, Ding L, Xiong Z, Zhu S (2012) Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. J Huazhong Univ Sci Technol Med Sci 32:451-457
27. Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457-462 (Pubitemid 46605910)